Skip to main content
Logo GMV

Main navigation

  • Sectors
    • Icono espacio
      Space
    • Icono Aeronáutica
      Aeronautics
    • Icono Defensa y Seguridad
      Defence and Security
    • Icono Sistemas Inteligentes de Transporte
      Intelligent Transportation Systems
    • Icono Automoción
      Automotive
    • Icono Ciberseguridad
      Cybersecurity
    • Icono Servicios públicos Digitales
      Digital Public Services
    • Icono Sanidad
      Healthcare
    • Icono Industria
      Industry
    • Icono Financiero
      Financial
    • Icono Industria
      Services
    • All Sectors

    Highlight

    20 + 1 Portugal
    Growing with the projects, staying for the people
  • Talent
  • About GMV
    • Get to Know the Company
    • History
    • Management Team
    • Certifications
    • Sustainability
  • Communication
    • News
    • Events
    • Blog
    • Magazine GMV News
    • Press Room
    • Media library
    • Latest from GMV

Secondary navigation

  • Products A-Z
  • Home
  • Communication
  • News
Back
New search
Date
  • Healthcare

GMV displays the new version of radiance in the ESTRO Turin

06/05/2016
Share
New version of radiance

GMV ha asistido a uno de los eventos con mayor reputación internacional en aspectos de la oncología de radiación y el tratamiento multidisciplinario del cáncer, el ESTRO 35.

Del 29 de Abril al 3 de Mayo, la sociedad interdisciplinaria ESTRO (European Society for Radiotherapy & Oncology) ha organizado un evento en Turín (Italia) donde los oncólogos de radiación, físicos médicos, biólogos y radioterapeutas han unido sus fuerzas con otras organizaciones en el campo de la oncología.

Carlos Illana, radiance Product Manager de GMV, mostró a los asistentes del evento la nueva versión del simulador radiance (v3). La crítica de los expertos fue muy positiva respecto a los avances realizados por GMV en su simulador de radioterapia intraoperatoria, gran parte de los físicos médicos presentes manifestaron lo necesario y ventajoso que actualmente resulta la planificación con radiance.

En ESTRO 35 se ha podido comprobar la colaboración de las organizaciones con otros especialistas en la materia, para involucrarse en el tratamiento multimodalidad y así asegurar la oportunidad del intercambio vital del conocimiento y la experiencia, además de la oportunidad para la creación de redes centradas en iniciativas de investigación y desarrollo que conduzcan a la excelencia en el cuidado de los pacientes.

Más información:
http://www.estro.org/binaries/content/assets/estro/conferences/estro35/estro-35_final-announcement.pdf

GMV has attended one of the most international reputation events in aspects of radiation oncology and the multidisciplinary treatment of cancer, ESTRO 35.

During the 29th of April and the 3rd of May, ESTRO (European Society for Radiotherapy & Oncology) interdisciplinary society has organized an event in Turin (Italy) where radiation oncologists, medical physicists, biologists and radiation oncologists have joined forces with other organizations in the field of oncology.

Carlos Illana, radiance GMV Product Manager, showed to the attendees of the event the new version of radiance (v3). The criticism of the experts was very positive about the progress made by GMV in its intraoperative radiotherapy simulator, and many of the medical physicists that were present expressed the necessity and the advantageous that can be the planning of radiance nowadays.

In ESTRO 35 it has been able to prove the collaboration of organizations with other specialists in the field, to engage in multimodality treatment and ensure the opportunity for the vital exchange of knowledge and experience, and the opportunity for creating focused networks research and development initiatives that lead to excellence in patient care.

More information:
http://www.estro.org/binaries/content/assets/estro/conferences/estro35/estro-35_final-announcement.pdf

Share

Related

GMV en Health Revolution Congress 2026
  • Healthcare
  • Cybersecurity
News
GMV spotlights regulation, cybersecurity, and digital health at Health Revolution Congress 2026
GMV presenta los resultados finales del proyecto SEPI-IA, una innovadora solución basada en IA para anticipar la evolución de enfermedades pulmonares
  • Healthcare
News
GMV presents the final results of the SEPI-IA project, a groundbreaking AI-based solution for predicting the progression of lung diseases
Health Revolution Congress 2026
  • Healthcare
Health Revolution Congress
27 May

Contact

Contact menu

  • Contact
  • GMV around the world

Blog

  • Blog

Sectors

Sectors menu

  • Space
  • Aeronautics
  • Defense and Security
  • Intelligent Transportation Systems
  • Automotive
  • Cybersecurity
  • Digital Public Services
  • Healthcare
  • Industry
  • Financial
  • Services
  • Talent
  • About GMV
  • Shortcut to
    • Press Room
    • News
    • Blog
    • Products A-Z
© 2026, GMV Innovating Solutions S.L.

Footer menu

  • Contact
  • Legal Notice
  • Privacy Policy
  • Cookie Policy

Footer Info

  • Commitment to the Environment
  • Financial Information